4//SEC Filing
PROGENICS PHARMACEUTICALS INC 4
Accession 0001447348-14-000034
CIK 0000835887operating
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:06 PM ET
Size
8.3 KB
Accession
0001447348-14-000034
Insider Transaction Report
Form 4
ISRAEL ROBERT J
Sr. VP, Medical Affairs
Transactions
- Exercise/Conversion
Common Stock
2014-11-21$5.35/sh+9,000$48,150→ 44,050 total - Sale
Common Stock
2014-11-21$7.00/sh−9,000$63,000→ 35,050 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2014-11-21$7.00/sh−9,000$63,000→ 21,000 totalExercise: $5.35From: 2011-07-01Exp: 2020-07-01→ Common Stock (9,000 underlying)
Footnotes (2)
- [F1]The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer.
- [F2]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000835887
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 5:06 PM ET
- Size
- 8.3 KB